Skip to main navigation Skip to search Skip to main content

Development of novel 5-FU modified siRNA against BCL-2 with enhanced efficacy and vehicle-free cellular uptake

  • Curamir Therapeutics Inc.
  • Stony Brook University

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)23-25
Number of pages3
JournalGenes and Diseases
Volume11
Issue number1
DOIs
StatePublished - Jan 2024

Fingerprint

Dive into the research topics of 'Development of novel 5-FU modified siRNA against BCL-2 with enhanced efficacy and vehicle-free cellular uptake'. Together they form a unique fingerprint.

Cite this